Geovax Labs EBIT

Geovax Labs (GOVX) currently reports a EBIT of $-21M as of June 2026. That compares with $-25M in the prior-year period — up 17.0% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Geovax Labs's EBIT history and peer comparisons.

Geovax Labs's EBIT increased from $-25M to $-21M — a 17.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Geovax Labs's EBIT of $-21M is lower than the Healthcare sector average of $22B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Geovax Labs reported $-21M in EBIT as of June 2026. That compares with $-25M in the prior-year period — up 17.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-21M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Geovax Labs, and consider following GOVX for alerts when major investors trade the stock.